仿生载体递送 mRNA:进展与挑战。
Delivery of mRNA Using Biomimetic Vectors: Progress and Challenges.
机构信息
School of Pharmaceutical Sciences, Key Laboratory of Targeting Therapy and Diagnosis for Critical Diseases, Zhengzhou University, Zhengzhou, 450001, China.
出版信息
Small. 2024 Oct;20(43):e2402715. doi: 10.1002/smll.202402715. Epub 2024 Jul 14.
Messenger RNA (mRNA) is an emerging class of therapeutic agents for treating a wide range of diseases. However, due to the instability and low cell transfection rate of naked mRNA, the expression of delivered mRNA in target cells or tissues in vivo requires delivery strategies. Biomimetic vectors hold advantages such as high biocompatibility, tissue specific targeting ability and efficient delivery mechanisms, potentially overcoming challenges faced by other delivery vectors. In this review, biomimetic vector-based mRNA delivery systems are summarized and discuss the possible challenges and prospects of such delivery systems, which may contribute to the progress and application of mRNA-based therapy in the biomedical field.
信使 RNA(mRNA)是一类新兴的治疗药物,可用于治疗多种疾病。然而,由于裸露的 mRNA 不稳定且细胞转染率低,因此需要通过递送来实现体内靶细胞或组织中所递送 mRNA 的表达。仿生载体具有高生物相容性、组织特异性靶向能力和高效的递送机制等优势,可能克服其他递送载体所面临的挑战。本文总结了基于仿生载体的 mRNA 递送系统,并讨论了这类递送系统可能面临的挑战和前景,这有助于推动基于 mRNA 的治疗方法在生物医学领域的进展和应用。